AHR — American Healthcare REIT Cashflow Statement
0.000.00%
- $9.67bn
- $11.14bn
- $2.26bn
Annual cashflow statement for American Healthcare REIT, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -53.3 | -73.4 | -76.9 | -35.6 | 70.8 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 31.5 | 91 | 48.6 | 101 | 89.3 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -93.5 | -37.8 | -55.8 | -68.7 | -30.3 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 17.9 | 148 | 98.5 | 176 | 294 |
| Capital Expenditures | -160 | -145 | -145 | -152 | -1,013 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 21.2 | 26.2 | 155 | 144 | -70.3 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -139 | -119 | 9.4 | -8.73 | -1,083 |
| Financing Cash Flow Items | -51.8 | -85.1 | -34.7 | -383 | -15.8 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 94.1 | -42.9 | -129 | -135 | 817 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -26.7 | -13.6 | -21.1 | 32.5 | 28.5 |